M4MM

Why the Endocannabinoid System Is the Future of Cannabis Medicine

NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The ...

Cannabis, Inflammation, and the Next Frontier in Root-Cause Medicine

NEW YORK- Cannabis medicine is moving beyond pain, sleep, and anxiety. One of the most important next frontiers may be inflammation, because the endocannabinoid system plays a direct role in how the body regulates immune ...

Why Metabolic Dysfunction May Be the Next Frontier for Cannabinoid Medicine

NEW YORK- Metabolism is the system that determines how the body produces, distributes, and uses energy, and it sits at the center of modern chronic disease. While it is often reduced to a discussion of ...

Hall of Flowers Relocates Northern California Event to Sacramento

LOS ANGELES – After eight years in Santa Rosa, the B2B Cannabis trade show Hall of Flowers is moving its Northern California event to the Cal Expo exhibition halls in Sacramento. The newly confirmed dates, ...

Vireo to Acquire FLUENT in All-Stock Deal

LOS ANGELES – Vireo Growth Inc. announced it has signed a definitive agreement to absorb FLUENT Corp. in an all-stock transaction, a deal that, if approved, would make Vireo the third-largest operator in medical-only Florida's ...

DEA Assigns Specific Schedule I Listing and Drug Code to HHC

WASHINGTON – The Drug Enforcement Administration (DEA) has issued a final rule that formally lists hexahydrocannabinol (HHC) as a Schedule I controlled substance with its own dedicated drug code. The notice, published in the Federal ...

Allied Market Research: Global Cannabis Market to Generate $149B by 2031

PORTLAND – A report recently published by Allied Market Research projects the global Cannabis market will reach $148.9 billion by 2031, up from $25.7 billion in 2021 – a nearly sixfold increase over a decade, ...

Why the Endocannabinoid System Is the Future of Cannabis Medicine

Cannabis, Inflammation, and the Next Frontier in Root-Cause Medicine

Why Metabolic Dysfunction May Be the Next Frontier for Cannabinoid Medicine

Washington Senate Committee Advances Home Cannabis Cultivation Bill

WASHINGTON – The Washington State Senate Labor & Commerce Committee has approved Senate Bill 6204, advancing legislation that would permit adults 21-plus to grow limited amounts of Cannabis at home for personal use. Introduced in ...

West Virginia and Mississippi Advance Ibogaine Research Bills

CHARLESTON–JACKSON – Lawmakers in West Virginia and Mississippi have advanced legislation to support research into ibogaine, a psychedelic compound derived from the iboga plant, with the goal of pursuing FDA approval for its use in ...

UCLA Partners with Terpene Belt Farms to Research Cannabis Flavors

LOS ANGELES – Terpene Belt Farms, a subsidiary of Nexus Agriscience, has been selected as the industry partner in a University of California-led research funded by a $1.23 million grant from the California Department of ...

Virgin Islands Sets Fall 2026 Target for Legal Cannabis Retail Launch

CHARLOTTE AMALIE – The U.S. Virgin Islands Office of Cannabis Regulation has accelerated its timeline for the start of licensed Cannabis sales, with executive director Joanne Moorhead stating that regulated retail operations are now expected ...

Florida Cannabis Legalization Initiative Fails to Qualify for 2026 Ballot

LOS ANGELES – Florida Secretary of State Cord Byrd announced that the Smart & Safe Florida campaign failed to submit the required number of valid signatures to qualify its proposed constitutional amendment for the ballot. ...

Psychedelic Pharmacists Foundation Launches to Advance Education and Research

PORTLAND – The Psychedelic Pharmacists Association (PPA) has launched the Psychedelic Pharmacists Foundation (PPF), a new nonprofit entity focused on education, research, and public awareness of responsible psychedelic medicine integration. The PPF will operate as ...

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – The Cannabis and Psychedelics worlds delivered a fresh wave of momentum that’s turning heads from boardrooms to ballot boxes. States pushed bold new frontiers in therapeutic access, millions of Americans embraced microdosing ...

DOJ Keeps Silent on Cannabis Rescheduling Updates

WASHINGTON – It's been more than 40 days since President Donald Trump signed an executive order calling for the swift rescheduling of Cannabis, yet the Department of Justice (DOJ) remains tight-lipped on any progress. A ...

High Tide Reports Q4 and Full FY 2025 Financial Results

CALGARY – High Tide Inc., the Canadian Cannabis retailer operating the Canna Cabana dispensary chain, released its audited financial results for the fourth quarter and full fiscal year ended October 31, 2025, reporting record revenue ...

Viridian Forecasts Accelerated M&A in Cannabis This Year

LOS ANGELES – Viridian Capital Advisors, a New York-based firm specializing in Cannabis finance and advisory services, has released its Key Insights for the U.S. Cannabis sector in 2026. The firm's analysts forecast a pickup ...

Trulieve Raises $60M in Senior Secured Notes

TALLAHASSEE – Trulieve Cannabis Corp. announced the completion of the second tranche of its private placement of 10.5% senior secured notes due in 2030, generating $60 million in principal. The closing follows the initial issuance ...

Canix Acquires Trym, Fits into Larger Consolidation Pattern in Cannabis

LOS ANGELES – San Francisco-based Canix, a provider of enterprise resource planning (ERP) software for Cannabis businesses, has acquired Trym, a specialized cultivation management platform. The deal combines Canix's comprehensive ERP system [which handles cultivation ...